Sort   by:  
 Page size 
UnknownTwo-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
Not available
S-EPMC9734710 | biostudies-literature
UnknownKTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Not available
S-EPMC11613962 | biostudies-literature
UnknownOutcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
Not available
S-EPMC4624003 | biostudies-literature
UnknownMeasuring the predictability of life outcomes with a scientific mass collaboration.
Not available
S-EPMC7165437 | biostudies-literature
UnknownCytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.
Not available
S-EPMC2674642 | biostudies-literature
UnknownSurgical treatment of moderate ischemic mitral regurgitation.
Not available
S-EPMC4303577 | biostudies-literature
UnknownProgression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
Not available
S-EPMC7953587 | biostudies-literature
UnknownTwo-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
Not available
S-EPMC4908820 | biostudies-literature
UnknownRisk for non-home discharge following surgery for ischemic mitral valve disease.
Not available
S-EPMC7874266 | biostudies-literature
UnknownCost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation.
Not available
S-EPMC6960356 | biostudies-literature
Sort   by:  
 Page size